Provided by Tiger Trade Technology Pte. Ltd.

Goldman Sachs Holdings

2,399.53
+16.750.70%
Number of Gainers:73
Number of Losers:24
Number of Flat:- -
PE:- -
High:2,401.83
Open:2,383.00
Low:2,383.00
Close:2,382.78
Volume:1.13B
Turnover:224.85B
Market Cap:53.18T
Float Cap:49.79T

Loading ...

Nasdaq Extends Gains to 1%, S&P 500 Currently Up 0.58%

Deep News
·
Sep 30

Anthropic's Potential $2 Trillion-Plus IPO Supports Robust AI Infrastructure Spending, Wedbush Says

MT Newswires Live
·
Sep 30

Adding Lilly's New Drug to Zepbound Helped People Lose up to 23% of Their Weight. but There were More Side Effects.

Dow Jones
·
Sep 30

UiPath, Snowflake Expand Collaboration

MT Newswires Live
·
Sep 30

Eli Lilly Says EloraTZP Combo Delivered 'Substantial' Weight Loss, A1C Reduction in Phase 2b Trial

MT Newswires Live
·
Sep 30

Lilly says participants on EloraTZP lost up to average 23.3% of weight in study

TIPRANKS
·
Sep 30

Amazon call volume above normal and directionally bullish

TIPRANKS
·
Sep 30

Is Ping An Healthcare And Technology (SEHK:1833) Undervalued After Its GlobalCare Launch?

Simply Wall St.
·
Sep 30

Shanghai Henlius Stock And The Amberstone Licensing Deal Explained

Simply Wall St.
·
Sep 30

Morgan Stanley Currently Down Seven Consecutive Days, on Track for Longest Losing Streak Since January 2024

Dow Jones
·
Sep 30

Snowflake Inc Stock (SNOW) Moved Up by 3.38% on Sep 30: What Investors Need To Know

TradingKey
·
Sep 30

Lilly's Eloratzp (Combination of Eloralintide and Tirzepatide) Delivered Greater Weight Loss and A1c Reduction VS. Tirzepatide 15 Mg in Adults with Obesity and Type 2 Diabetes

THOMSON REUTERS
·
Sep 30

Eli Lilly: Plans to Initiate Phase 3 Studies of Eloratzp Co-Formulation Product by 2026 End Using Optimized Escalation Schedule

THOMSON REUTERS
·
Sep 30

Eli Lilly: at 48 Weeks, All Combinations of Eloratzp Met Primary & Secondary Endpoints

THOMSON REUTERS
·
Sep 30

Experimental Lilly Combination Drug Tops Zepbound in Weight-Loss Trial

Reuters
·
Sep 30

Eli Lilly: Participants Taking Eloratzp Lost up to Average of 54.1 Lbs (23.3%) VS. 34.4 Lbs (14.8%) with Tirzepatide 15 Mg

THOMSON REUTERS
·
Sep 30

Cerebras Stock Falls Again Because so Much Depends on OpenAI

Dow Jones
·
Sep 30

US FTC Conducting Industry-Wide AI Probe After Hugging Face Incident, Source Says

Reuters
·
Sep 30

CoreWeave Offers Nvidia's Vera Chip for AI Agents

MT Newswires Live
·
Sep 30

BlackRock Advisors Discloses Net Short Position in Renault Shares

Reuters
·
Sep 30